Executive Summary
- When AI contributes to a clinical or medical decision, Texas law keeps responsibility with the licensed practitioner, not with the AI tools or software. Senate Bill 1188 explicitly permits healthcare providers to use artificial intelligence in diagnosis and treatment, while also reinforcing that the practitioner remains accountable for the medical judgment involved.
- The absence of AI malpractice case law is not the absence of risk. When AI-related disputes reach courts, they are likely to be evaluated through existing doctrines like professional negligence, informed consent, and documentation adequacy, with the analysis returning to the practitioner’s conduct rather than the technology.
- The Department of Justice’s scrutiny of Practice Fusion’s platform which was allegedly influenced by financial arrangements shows regulators focus on whether technology improperly influenced independent clinical judgment.
- The defining issue for healthcare organizations is governance. Providers that establish oversight structures, practitioner-review procedures, and documentation standards will be better positioned to use AI while managing regulatory and litigation exposure.
When AI contributes to a clinical or healthcare decision, who is responsible for the patient outcome?
Artificial intelligence is rapidly moving from the periphery of healthcare into the center of clinical operations. What began as a tool primarily associated with radiology and research is now being integrated throughout the healthcare ecosystem. Hospitals, physician groups, urgent care centers, and other healthcare providers are increasingly using AI-enabled technologies to assist with diagnostic imaging, pathology review, patient monitoring, risk stratification, treatment recommendations, documentation, and clinical decision support.
The growing adoption of these technologies reflects a broader transformation occurring throughout healthcare. Providers face increasing pressure to improve outcomes, reduce administrative burdens, manage labor shortages, and process ever-expanding volumes of patient data. Artificial intelligence offers the promise of helping healthcare organizations accomplish those objectives more efficiently and, in some cases, more accurately.
Yet as AI becomes more deeply integrated into patient care, a fundamental legal question emerges: When artificial intelligence contributes to a clinical decision, who bears responsibility for the outcome?
Texas addressed that question through Senate Bill 1188, enacted during the 89th Legislative Session in 2025. Although the legislation expressly permits healthcare practitioners to use artificial intelligence in diagnosis and treatment, it simultaneously reinforces a principle that has long occupied a central place within healthcare regulation: the licensed healthcare practitioner remains responsible for the exercise of professional judgment.
The significance of the legislation extends beyond healthcare technology. More broadly, it provides insight into how lawmakers and regulators are likely to approach artificial intelligence in healthcare moving forward. Rather than creating a separate legal framework for AI-assisted medicine, Texas has largely integrated artificial intelligence into existing concepts of professional accountability, patient protection, and clinical responsibility.
Artificial Intelligence and the Existing Standard of Care
Long before artificial intelligence entered the clinical setting, healthcare practitioners were already subject to extensive professional obligations governing diagnosis, treatment, and patient care. Physicians and other licensed professionals have long been required to exercise independent judgment consistent with the applicable standard of care.
Artificial intelligence does not eliminate those obligations. Instead, it introduces a new category of information that may inform clinical decision-making.
This distinction is significant because healthcare differs from many other industries currently adopting AI technologies. In some sectors, automation is designed to replace human involvement in routine decision-making. Healthcare operates under a different framework. Clinical decisions directly affect patient safety, bodily integrity, and health outcomes. As a result, the law has historically placed responsibility on licensed professionals rather than on the tools they use.
From a legal perspective, artificial intelligence is increasingly being treated as another clinical-support tool. It may assist practitioners in identifying patterns, evaluating risks, or analyzing data that might otherwise go unnoticed. It does not, however, assume responsibility for the ultimate decision.
Texas’s recent legislative developments reflect this approach. Rather than creating an AI-specific standard of care, lawmakers elected to preserve existing concepts of practitioner accountability while clarifying that AI-generated information must remain subject to human review and oversight.
Senate Bill 1188 Signals Texas’s Regulatory Approach to Healthcare AI
The most noteworthy aspect of Senate Bill 1188 may not be what it changes, but what it preserves. The legislation expressly permits healthcare practitioners to use artificial intelligence for diagnostic and treatment-related purposes. In doing so, Texas joins a growing number of jurisdictions that appear reluctant to impede innovation through broad restrictions on AI adoption.
At the same time, the statute reinforces that healthcare practitioners remain responsible for the medical judgment involved in patient care. The use of artificial intelligence does not transfer responsibility to a software vendor, algorithm, platform, or model developer. Instead, practitioners remain accountable for evaluating AI-generated information and determining whether it is appropriate for a particular patient.
This approach reflects a broader regulatory trend. Policymakers increasingly recognize the potential benefits of artificial intelligence, including improved efficiency, enhanced pattern recognition, and faster analysis of large quantities of clinical information. However, regulators also appear unwilling to separate technological innovation from human accountability.
As a result, Texas’s regulatory framework can largely be understood as a balance between innovation and oversight. Artificial intelligence may become part of the clinical workflow, but it does not become the decision maker.
The Emerging Question of Liability in AI and Healthcare
One of the more interesting aspects of AI regulation is that the technology is evolving considerably faster than the law. At present, there remains relatively little reported case law directly addressing medical malpractice claims arising from AI-assisted diagnosis and treatment. That absence of precedent should not be interpreted as an absence of risk. Rather, it reflects the reality that widespread clinical adoption of artificial intelligence is still relatively new and that courts are only beginning to confront disputes involving AI-related healthcare decisions.
When those disputes begin reaching courts with greater frequency, judges are unlikely to treat artificial intelligence as creating an entirely new category of liability. Instead, healthcare providers will likely find AI-related conduct evaluated through existing legal doctrines.
Professional negligence claims may focus on whether a provider improperly relied upon an AI-generated recommendation without conducting an adequate independent review. Licensing boards may evaluate whether practitioners appropriately validated AI-generated information before incorporating it into patient care. Plaintiffs may seek to frame disputes through informed consent theories, documentation deficiencies, or allegations that material information was withheld from a patient.
In each of these situations, the legal analysis ultimately returns to the conduct of the healthcare professional rather than the technology itself.
For that reason, the principal legal significance of Senate Bill 1188 may not be the creation of new liability. Instead, the statute may serve as a legislative benchmark confirming that healthcare practitioners remain responsible for independently evaluating AI-generated information before acting upon it.
What the Purdue Pharma and Practice Fusion Investigation Reveals About AI Enforcement
Although courts have only begun addressing AI-related healthcare disputes, federal regulators have already demonstrated how they are likely to approach technology-driven clinical decision-making.
One of the most frequently cited examples involves the Department of Justice’s scrutiny of Practice Fusion, an electronic health record provider, and its relationship with Purdue Pharma. According to government allegations, clinical decision-support alerts embedded within the platform were allegedly influenced by financial arrangements and designed to encourage opioid prescribing under certain circumstances.
The significance of the matter extends well beyond opioids or electronic health records. The government’s concern was not simply that technology was being used as part of the clinical workflow. Instead, regulators focused on whether clinical recommendations were being influenced in a manner that undermined independent medical judgment.
That distinction is likely to become increasingly important as artificial intelligence becomes more sophisticated. Regulators appear far less concerned with the existence of advanced technology than with the possibility that technology may influence clinical decisions in a way that compromises provider independence, patient welfare, or professional accountability.
For healthcare organizations adopting AI tools, the lesson is straightforward: oversight matters. Regulators are likely to evaluate whether practitioners remained actively engaged in the decision-making process and whether the technology supported, rather than replaced, professional judgment.
Why This Matters for Healthcare Organizations
Much of the public discussion surrounding artificial intelligence focuses on technological capabilities. From a legal and operational perspective, however, the more important issue may be governance.
As AI becomes integrated into diagnosis, treatment planning, patient monitoring, and clinical operations, healthcare organizations must determine how these systems will be implemented, supervised, documented, and evaluated. Questions regarding oversight, accountability, documentation, training, and patient communication are likely to become increasingly important.
Organizations that treat AI as a purely technological initiative may overlook the compliance, governance, and risk-management considerations that accompany clinical adoption. Conversely, healthcare providers that implement thoughtful oversight structures will be better positioned to realize the benefits of artificial intelligence while reducing regulatory and litigation risk.
The challenge is not whether healthcare organizations should utilize artificial intelligence. The challenge is ensuring that AI is incorporated into clinical workflows in a manner consistent with existing professional and regulatory obligations.
Practical Considerations for Healthcare Organizations
As artificial intelligence becomes increasingly integrated into clinical workflows, the legal question is not simply whether AI is used, but how it is governed. Organizations that adopt AI without appropriate oversight may face increased exposure when adverse outcomes occur. Conversely, providers that establish governance frameworks, practitioner review procedures, and documentation standards will be better positioned to utilize AI while managing regulatory and litigation risk.
A practical compliance checklist may include:
Governance
- Create an inventory of AI tools currently in use.
- Identify whether each tool contributes to diagnosis, treatment, prevention, monitoring, or documentation.
- Designate responsibility for AI oversight.
Policies
- Adopt written AI governance policies.
- Define practitioner review requirements.
- Establish documentation standards.
- Create escalation procedures when AI recommendations conflict with clinical judgment.
Documentation and Oversight
- Define how practitioner review of AI-generated recommendations will be documented.
- Establish procedures for auditing AI-assisted clinical decisions.
- Periodically evaluate whether AI tools are performing as intended and consistent with clinical standards.
Looking Ahead
Artificial intelligence will undoubtedly become a permanent feature of modern healthcare. The question is no longer whether providers will use AI. The more meaningful question is how courts, regulators, and patients will evaluate provider conduct when AI becomes a routine part of clinical decision-making.
Texas’s answer, at least for now, is relatively clear. Artificial intelligence may assist practitioners. It may improve efficiency, identify patterns, and support better-informed decisions. It may become an indispensable part of modern healthcare delivery. What it does not do is assume responsibility for patient care.
As healthcare organizations continue adopting AI-enabled technologies, the defining legal issue is unlikely to be the technology itself. Instead, courts and regulators will continue asking a much more traditional question: did the healthcare practitioner exercise appropriate professional judgment?
For the foreseeable future, that question—not the capabilities of the technology—will likely remain the central legal standard governing AI-assisted healthcare.
FAQs
Q: If a doctor uses AI to help make a diagnosis, who is legally responsible for the outcome?
A: The licensed practitioner. Under Texas Senate Bill 1188, using artificial intelligence does not transfer responsibility to a software vendor, algorithm, or model developer. The practitioner remains accountable for independently evaluating AI-generated information and determining whether it is appropriate for a particular patient.
Q: Does Texas have a separate standard of care for AI-assisted medical decisions?
A: No. Rather than creating an AI-specific standard, Texas preserved the existing standard of care and existing concepts of professional accountability. AI does not change the practitioner’s underlying obligation to exercise independent professional judgment.
Q: What can a healthcare organization do before adopting AI tools into patient care?
A: Build a governance framework before problems arise. That means inventorying which AI tools are in use and what each one contributes to, adopting written oversight policies, and defining practitioner-review and documentation requirements, among other actions.
Disclaimer: The information provided in this blog/article is for general informational purposes only and does not constitute legal advice. While we strive to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability with respect to the blog/article or the information for any purpose. The content of this blog is intended to convey general information and may not reflect current legal developments, verdicts, or settlements. Any reliance you place on such information is therefore strictly at your own risk. The content is not intended to be a substitute for legal advice from a qualified attorney licensed in your state.
Your use of the information in this blog/article does not create an attorney-client relationship between you and Elena Villasenor Sullivan or Endereza Law, PLLC. Contacting us through this blog does not establish an attorney-client relationship. Please do not send any confidential information to us until such time as an attorney-client relationship has been established. Unless otherwise stated, the attorneys listed on this blog are not certified by the Texas Board of Legal Specialization.
